ATLANTA, Dec. 15, 2015 (GLOBE NEWSWIRE) -- The Genetics Policy Institute (GPI) and Regenerative Medicine Foundation (RMF) brought over a thousand scientists, clinicians, industry leaders, investors, government officials and patient advocates together for a three day conference designed to find cures and end human suffering at the 11th annual World Stem Cell Summit and the second annual RegMed Capital Conference, co-located at the Hyatt Regency in Atlanta, Georgia.
"For 11 years, the Genetics Policy Institute has gathered leaders from the stem cell and regenerative medicine community to share the latest scientific discoveries, pathways to deliver treatments to patients, and how to accelerate investment in this lifesaving research," said Bernard Siegel, Founder of the World Stem Cell Summit & RegMed Capital Conference and Executive Director of GPI.
Sessions at the 11th annual World Stem Cell Summit covered a range of disease areas and medical conditions including neurological disease, cardiovascular issues, spinal cord injury, cancer, HIV/AIDS, aging and more.
Speakers such as Dr. Robert M. Califf, President Obama's nominee to lead the Food and Drug Administration, discussed the role of regulations and pathways to connect research discoveries and patients in safe and ethical ways.
The impact of microgravity when studying stem cells on the International Space Station was a hot topic at the Summit as the Center for the Advancement of Science in Space (CASIS) led sessions on how space is a platform for innovation that can benefit all humankind.
Participants at the Summit also learned from the international community. With attendees from over 35 countries, sessions led by academic and industry leaders from outside the United States shared models for regulation and collaboration that can accelerate clinical application of regenerative medicine in Japan.
"With the convergence of innovative technologies, medical research is on the brink of breakthrough discoveries to tackle chronic disease," said Siegel. "The World Stem Cell Summit created a forum to accelerate the field by expanding knowledge and providing a platform to forge collaborations and facilitate progress."
The recently merged, Genetics Policy Institute/Regenerative Medicine Foundation, is a 501c3 nonprofit public interest organization, with the mission to promote public awareness, societal support and public policy initiatives for the fields of regenerative medicine, stem cell research and other advanced therapies, thereby accelerating their application in medicine for the purpose of delivering cures. We pursue this mission through production of our flagship annual World Stem Cell Summit & RegMed Capital Conference, publication of the annual World Stem Cell Report and newsletters, Stem Cell Action Awards, the Stem Cell Action Coalition, social media campaigns, special projects, speaking engagements, teaching initiatives and strategic collaborations. Learn more at http://www.genpol.org.
The 11th Annual World Stem Cell Summit & RegMed Capital Conference, the flagship meeting of the international stem cell community, was organized by the Genetics Policy Institute. The Summit (WSCS15) was organized by Genetics Policy Institute/Regenerative Medicine Foundation, The Georgia Center for Regenerative Engineering & Medicine (Emory University, Georgia Tech, University of Georgia), Mayo Clinic, Kyoto University Institute for Cell-Material Sciences (iCeMS), BioBridge Global, Wake Forest Institute for Regenerative Medicine and The New York Stem Cell Foundation. The goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies, bringing global stakeholders together to solve global challenges. The Summit forges collaborations to advance cell therapies, while creating a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy.
Learn more at www.WorldStemCellSummit.com. Follow @WSCSummit on Twitter.
Media Contact: Judith Selzer, 561.909.8415
CONTACT: Judith Selzer 561.909.8415 Judith@Selzer360.com
Source:Genetics Policy Institute